Drug profile · INN
lumateperone
LUMATEPERONE
lumateperone (LUMATEPERONE) is a serotonin 2a (5-ht2a) receptor antagonist. Current US regulatory status: approved.
Drug details — lumateperone
- US status
- approved
- Class
- —
- Route
- —
- Patents
- 0
- Programs
- 0
- Data quality
- 0.81
Quick answer
lumateperone (LUMATEPERONE) is a serotonin 2a (5-ht2a) receptor antagonist. Current US regulatory status: approved.
Key facts
Mechanism of action
Serotonin 2a (5-HT2a) receptor antagonist
Primary target: D(2) dopamine receptor
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Related & competitor drugs
Frequently asked questions
What is lumateperone?
lumateperone (LUMATEPERONE) is a serotonin 2a (5-ht2a) receptor antagonist. Current US regulatory status: approved.
What is the brand name for lumateperone?
LUMATEPERONE is a marketed brand name for lumateperone. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of lumateperone?
lumateperone has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.